Mercury Pharmaceuticals

We are de-risking biomedical innovations, while turning biomedical knowledge into social and economic value.

Stay Informed!

Study highlights the hidden dangers of permanent daylight saving time

29

Oct 2026

Study highlights the hidden dangers of permanent daylight saving time

In July 2026, the US House passed legislation to make daylight saving time (DST) permanent. But a new analysis of the consequences of the "Sunshine Protection Act," reported in the Cell Press journal Current Biology on October 29, finds that this legislation would come with serious safety consequences for millions of schoolchildren across the US who would have to leave for school before sunrise, when fatal crashes with pedestrians are more likely, for much of the school year.

Two rounds of prenatal STI screening lower preterm birth risk

29

Oct 2026

Two rounds of prenatal STI screening lower preterm birth risk

Screening and treating pregnant patients for three common sexually transmitted infections (STIs) twice during pregnancy was associated with a 23 percent lower risk of preterm birth compared with standard care, according to a randomized clinical trial published in Clinical Infectious Diseases from researchers at the University of Pennsylvania and University of Southern California.

MERCURY trials

Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more

Cancer

Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more

Neuroscience

Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more

Mercury Pharmaceuticals

Why Us?

Strong experience in academic research and technology transfer makes us understand your goals and motivations as a technology originator.
Our experience in drug development from discovery to clinical and commercial stages makes us an insider player within the biopharmaceutical industry.
Smart approach to project management that helps speed up development stages and decision making.
Availability of own investment up to 2m€ per project allows us to reach the next value milestone.